Corvus Pharmaceuticals, Inc.
CRVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626971
No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Corvus Pharmaceuticals, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- −4 vs. Q3 2023
- Shares held
- 19.2M
- −2.90K (0.0%) vs. Q3 2023
- Total value
- $33.8M
- +$5.75M (+20.5%) vs. Q3 2023
- New holders
- 3
- 13 more added
- Sold out
- 7
- 11 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 173 | $1.06B |
| Q1 2026 | 164 | $1.02B |
| Q4 2025 | 124 | $359.4M |
| Q3 2025 | 103 | $312.7M |
| Q2 2025 | 92 | $167.1M |
| Q1 2025 | 88 | $115.4M |
| Q4 2024 | 86 | $202.0M |
| Q3 2024 | 62 | $158.5M |
| Q2 2024 | 47 | $50.2M |
| Q1 2024 | 47 | $31.9M |
| Q4 2023 | 48 | $33.8M |
| Q3 2023 | 52 | $28.0M |
| Q2 2023 | 52 | $44.6M |
| Q1 2023 | 37 | $18.9M |
| Q4 2022 | 42 | $18.2M |
| Q3 2022 | 48 | $18.1M |
| Q2 2022 | 47 | $25.4M |
| Q1 2022 | 57 | $44.9M |
| Q4 2021 | 62 | $66.7M |
| Q3 2021 | 61 | $136.4M |
| Q2 2021 | 50 | $63.2M |
| Q1 2021 | 49 | $62.8M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Corvus Pharmaceuticals, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 6,943,654 | $12.2M | 0.24% | 00.0% | Unchanged |
| Adams Street Partners LLC | 3,275,616 | $5.77M | 1.78% | 00.0% | Unchanged |
| Samlyn Capital, LLC | 2,496,259 | $4.39M | 0.10% | +90,495+3.8% | Added |
| BVF Inc | 1,370,947 | $2.41M | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,350,633 | $2.38M | 0.00% | +3,701+0.3% | Added |
| Renaissance Technologies LLC | 587,432 | $1.03M | 0.00% | +165,689+39.3% | Added |
| BlackRock Inc. | 520,551 | $916.2K | 0.00% | −700−0.1% | Reduced |
| Towerview LLC | 436,873 | $768.9K | 0.47% | +94,395+27.6% | Added |
| Geode Capital Management, LLC | 360,380 | $634.4K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 259,655 | $457.0K | 0.00% | +67,149+34.9% | Added |
| Two Sigma Advisers, LP | 235,600 | $414.7K | 0.00% | −13,300−5.3% | Reduced |
| Susquehanna International Group, LLP | 220,296 | $387.7K | 0.00% | +92,328+72.1% | Added |
| Two Sigma Investments, LP | 180,704 | $318.0K | 0.00% | −92,303−33.8% | Reduced |
| Bridgeway Capital Management, LLC | 149,300 | $262.8K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 138,403 | $243.6K | 0.00% | 00.0% | Unchanged |
| Connor, Clark & Lunn Investment Management Ltd. | 71,208 | $125.3K | 0.00% | +325+0.5% | Added |
| MYDA Advisors LLC | 71,011 | $125.0K | 0.06% | +2,197+3.2% | Added |
| Northern Trust Corp | 65,017 | $114.4K | 0.00% | 00.0% | Unchanged |
| Jackson Square Capital, LLC | 63,773 | $112.2K | 0.04% | 00.0% | Unchanged |
| Hikari Power Ltd | 49,959 | $88.0K | 0.01% | 00.0% | Unchanged |
| Simplex Trading, LLC | 49,631 | $87.0K | 0.00% | +10,138+25.7% | Added |
| Millennium Management LLC | 40,835 | $71.9K | 0.00% | −67,189−62.2% | Reduced |
| Group One Trading, L.P. | 36,664 | $64.5K | 0.00% | +9,565+35.3% | Added |
| XTX Topco Ltd | 23,415 | $41.2K | 0.01% | +4,171+21.7% | Added |
| Jane Street Group, LLC | 23,095 | $40.6K | 0.00% | +23,095 | New |
| Bank of New York Mellon Corp | 21,219 | $37.3K | 0.00% | 00.0% | Unchanged |
| Commerce Bank | 20,000 | $35.2K | 0.00% | 00.0% | Unchanged |
| American Century Companies Inc | 18,462 | $32.5K | 0.00% | −292−1.6% | Reduced |
| Charles Schwab Investment Management Inc | 15,668 | $27.6K | 0.00% | 00.0% | Unchanged |
| Resources Investment Advisors, LLC. | 12,400 | $21.8K | 0.00% | +12,400 | New |
| Dimensional Fund Advisors LP | 11,924 | $21.0K | 0.00% | −2,966−19.9% | Reduced |
| Gillespie Robinson & Grimm Inc | 11,480 | $20.2K | 0.00% | 00.0% | Unchanged |
| Whittier Trust Co of Nevada Inc | 11,200 | $19.6K | 0.00% | 00.0% | Unchanged |
| Masso Torrence Wealth Management Inc. | 10,000 | $17.6K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,503 | $15.0K | 0.00% | −16,234−65.6% | Reduced |
| Citadel Advisors LLC | 7,654 | $13.5K | 0.00% | +7,471+4,082.5% | Added |
| UBS Group AG | 6,700 | $11.8K | 0.00% | 00.0% | Unchanged |
| Northwest Capital Management Inc | 3,397 | $5.98K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,200 | $2.11K | 0.00% | −1,200−50.0% | Reduced |
| Natixis | 800 | $1.41K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 791 | $1.39K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 679 | $1.20K | 0.00% | −69,228−99.0% | Reduced |
| Wells Fargo & Company | 260 | $458 | 0.00% | +13+5.3% | Added |
| IFP Advisors, Inc | 24 | $42 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 22 | $39 | 0.00% | −3,150−99.3% | Reduced |
| Parallel Advisors, LLC | 20 | $35 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1 | $2 | 0.00% | −13,681−100.0% | Reduced |
| Royal Bank of Canada | 122 | $0 | 0.00% | +122 | New |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −198,220−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −49,324−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,366−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −15,617−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −13,050−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,232−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1,101−100.0% | Sold out |